GXXY.US Galexxy Holdings Inc
- Market cap
- USD 28.4K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2025.
Is GXXY.US undervalued?
Graham numberThe Graham number of Galexxy Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Galexxy Holdings Inc fundamental analysis
No fundamental analysis for Galexxy Holdings Inc yet.
Galexxy Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Galexxy Holdings Inc
Galexxy Holdings, Inc. operates as a health and wellness company. It engages in the provision of various functional mushroom products; and operation of a hemp store. The company was formerly known as AgTech Global International, Inc. and changed its name to Galexxy Holdings, Inc. in March 2022. Galexxy Holdings, Inc. was incorporated in 2000 and is based in Dana Point, California. Galexxy Holdings, Inc. was formerly a subsidiary of PracticeXpert, Inc.
Full company profileGalexxy Holdings Inc financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Galexxy Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2010 | 2011 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | - | - | 30.21 | 20.0K | - | 536K | 1.06M | 118K | - |
| Gross Profit | - | - | 1.87 | - | - | 283K | 429K | -17.8K | - |
| Operating Income | - | - | -174.00 | -161K | -743K | -1.47M | -1.61M | -2.05M | -3.79K |
| EBITDA | - | - | 174K | 20.00 | -743K | -17.5M | -1.56M | -3.09M | -3.79K |
| Net Income | - | - | -174.00 | -161K | -743K | -17.6M | -1.34M | -2.98M | -3.79K |
| EPS | - | - | 0.00 | 0.00 | 0.00 | -0.09 | -0.01 | -0.01 | 0.00 |
| Balance Sheet | |||||||||
| Total Assets | - | - | 42.4K | 61.4K | 5.06M | 588K | 887K | 74.2K | 74.3K |
| Total Liabilities | - | - | 1.13M | 435K | 620K | 1.51M | 1.41M | 771K | 773K |
| Shareholders' Equity | - | - | -1.09M | -374K | 4.44M | -955K | -798K | -814K | -815K |
| Cash & Short-term Investments | - | - | 5.70K | - | 2.29K | 118K | 163K | 152.00 | 268.00 |
| Total Debt | - | - | 500K | 82.4K | 315K | 845K | 823K | 216K | 218K |
| Cash Flow | |||||||||
| Operating Cash Flow | -229K | -229K | -229.00 | -97.0K | -552K | -675K | -1.98M | -763K | -8.17K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 5.00 | 3.43K | 156K | 70.2K | 1.00 | 16.00 |
| Free Cash Flow | - | - | -229.00 | -97.0K | -556K | -831K | -1.93M | -763K | -8.16K |
| Ratios | |||||||||
| ROE | - | - | - | - | -16.7% | - | - | - | - |
| ROA | - | - | -0.4% | -262.6% | -14.7% | -2,996.6% | -151.4% | -4,022.5% | -5.1% |
| Net Profit Margin | - | - | -576.0% | -806.2% | - | -3,286.3% | -127.2% | -2,517.5% | - |
| Debt to Equity | - | - | - | - | 0.07x | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Galexxy Holdings Inc dividends
Galexxy Holdings Inc has not paid dividends in the last 8 fiscal years.
Who owns Galexxy Holdings Inc
Ownership data of Galexxy Holdings Inc is not available yet.
Galexxy Holdings Inc company profile
- Company name
- Galexxy Holdings Inc
- Ticker
- GXXY.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 2
- Fiscal year end
- December
- Address
- 32565 B Golden Lantern, Dana Point, CA, United States, 92660
- Phone
- 949 418 7450
- Website
- galexxyholdings.com
About Galexxy Holdings Inc
Galexxy Holdings, Inc. operates as a health and wellness company. It engages in the provision of various functional mushroom products; and operation of a hemp store. The company was formerly known as AgTech Global International, Inc. and changed its name to Galexxy Holdings, Inc. in March 2022. Galexxy Holdings, Inc. was incorporated in 2000 and is based in Dana Point, California. Galexxy Holdings, Inc. was formerly a subsidiary of PracticeXpert, Inc.
Galexxy Holdings Inc management
3- Mr. George T. RothPresident & Director · born 1938
- Mr. Michael BiagiChief Executive Officer
- Ms. Rachel FyffeVice President of Communications